1) Katzenstein AL, Myers JL : Idiopathic pulmonary fibrosis : clinical relevance of pathologic classification. Am J Respir Crit Care Med 157:1301-1315,1998
2) American Thoracic Society, European Respiratory Society : American Thoracic Society/European Respiratory Society International Multidisciplinary Consensus Classification of the Idiopathic Interstitial Pneumonias. This joint statement of the American Thoracic Society (ATS), and the European Respiratory Society (ERS) was adopted by the ATS board of directors, June 2001 and by the ERS Executive Committee, June 2001.Am J Respir Crit Care Med 165:277-304,2002
3) Travis WD, Hunninghake G, King Jr TE, et al : Idiopathic nonspecific interstitial pneumonia : report of an American Thoracic Society project. Am J Respir Crit Care Med 177:1338-1347,2008
4) 高橋弘毅,白鳥正典:びまん性肺疾患と血清マーカー.日内会誌 95:986-992,2006
5) 出原賢治,有馬和彦,白石裕士,他:ペリオスチンによる気管支喘息の病態形成機序.臨床免疫・アレルギー科(印刷中)
6) Norris RA, Moreno-Rodriguez R, Hoffman S, et al : The many facets of the matricelluar protein periostin during cardiac development, remodeling, and pathophysiology. J Cell Commun Signal 3:275-286,2009
7) Ruan K, Bao S, Ouyang G : The multifaceted role of periostin in tumorigenesis. Cell Mol Life Sci 66:2219-2230,2009
8) Okamoto M, Hoshino T, Kitasato Y, et al : Periostin, a matrix protein, is a novel biomarker for idiopathic interstitial pneumonias. Eur Respir J 37:1119-1127,2011